CLINICAL_TRIALS
trial_result
· 2018-04-19
Clinical Trial Update: Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage [Phase 4]
Summary
A Phase 4 trial evaluated the safety and effectiveness of repeated QUTENZA patches (capsaicin 8% patch) for neuropathic pain due to nerve damage, including post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Neuralgia, Postherpetic | Phase 4 | Status: COMPLETED